CompaniesTrogen Biotechnologies

Trogen Biotechnologies

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

125

By Phase

PHASE2: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details

Recent Trials

NCT03799510Collaborator
Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children
PHASE2Completed
95 participants
Started: Dec 13, 2018 · Completed: Aug 7, 2019
NCT03041766Collaborator
Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions
PHASE2Completed
30 participants
Started: Dec 6, 2016 · Completed: Jun 2, 2017